The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real ...

Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. But with the proper planning and an agile approach, they can be more ...

"I think the common thread is probably that there's a person that's been victimized or discarded or forgotten about by a ...

Driven by attractive margins and significant growth potential, the Indian diagnostics sector has emerged as a preferred bet ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Closing of the Merger Expected in Early August DUBLIN, July 17, 2025 /PRNewswire/ -- Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable ...

When it comes to powerful packaging solutions, Yuyao Weiyong Packing Co. Ltd stands out like a shining star in the crowded world of packaging manufacturers.

In a new innovative and groundbreaking medical achievement, Abu Dhabi Stem Cells Centre (ADSCC) has manufactured the UAE's ...

Abbott LaboratoriesABT is slated to report second-quarter 2025 results on July 17, before the opening bell. The company ...